Follow the 일양약품 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 일양약품 has logged 37 public disclosures. Market capitalisation: €152.9bn. The latest transaction was reported on 28 May 2026 (Purchase). Among the most active insiders: 정유석. Every trade is accessible without an account.
37
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,000 of 26,270 companies
47.8
score / 100
Value
52
Quality
43
FCF yld1.0%
Earn yld4.5%
EV/EBITDA11.4x
ROE8.1%
Gross mgn43%
Net mgn2.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
